Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1994 Jan;1(1):38–43. doi: 10.1128/cdli.1.1.38-43.1994

Autoimmune hemolytic anemia in chronic mucocutaneous candidiasis.

B I Oyefara 1, H C Kim 1, R N Danziger 1, M Carroll 1, J M Greene 1, S D Douglas 1
PMCID: PMC368193  PMID: 7496919

Abstract

Chronic mucocutaneous candidiasis is an immunodeficiency disease characterized by T-cell dysregulation and chronic superficial candidal infections. We report on three patients with chronic mucocutaneous candidiasis who developed autoantibodies to erythrocytes. Our first patient, a 19-year-old female, developed autoimmune hemolytic anemia (AIHA) that required multiple courses of treatment, including corticosteroids, intravenous immunoglobulin, and danazol. During the last exacerbation of AIHA, intensive treatment with corticosteroids and intravenous immunoglobulin failed and yet the patient responded to plasmapheresis. Our second patient, a 21-year-old male, developed AIHA which responded to oral corticosteroid therapy. Our third patient, a 6-year-old female without evidence of hemolysis, was found to have erythrocyte autoantibodies on routine screening. These three patients had positive direct antiglobulin tests, and the first patient had both immunoglobulin G (IgG) and IgM erythrocyte autoantibodies, while the remaining two patients had only IgG autoantibody. This is the first report of the association of AIHA with chronic mucocutaneous candidiasis. We suggest that all patients with chronic mucocutaneous candidiasis be screened periodically for erythrocyte autoantibodies. Plasmapheresis, a safe ancillary procedure in the management of AIHA, may be life-saving in some cases. The occurrence of erythrocyte autoantibodies in mucocutaneous candidiasis may be related to immunoregulatory disorders in this disease.

Full text

PDF
38

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahn Y. S., Fernandez L. F., Kim C. I., Mylvaganam R., Temple J. D., Jr, Cayer M. L., Harrington W. J. Danazol therapy renders red cells resistant to osmotic lysis. FASEB J. 1989 Feb;3(2):157–162. doi: 10.1096/fasebj.3.2.2914627. [DOI] [PubMed] [Google Scholar]
  2. Ahn Y. S., Harrington W. J., Mylvaganam R., Ayub J., Pall L. M. Danazol therapy for autoimmune hemolytic anemia. Ann Intern Med. 1985 Mar;102(3):298–301. doi: 10.7326/0003-4819-102-3-298. [DOI] [PubMed] [Google Scholar]
  3. Arulanantham K., Dwyer J. M., Genel M. Evidence for defective immunoregulation in the syndrome of familial candidiasis endocrinopathy. N Engl J Med. 1979 Jan 25;300(4):164–168. doi: 10.1056/NEJM197901253000403. [DOI] [PubMed] [Google Scholar]
  4. Atkinson J. P., Schreiber A. D., Frank M. M. Effects of corticosteroids and splenectomy on the immune clearance and destruction of erythrocytes. J Clin Invest. 1973 Jun;52(6):1509–1517. doi: 10.1172/JCI107325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Besa E. C. Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders. Am J Med. 1988 Apr;84(4):691–698. doi: 10.1016/0002-9343(88)90106-4. [DOI] [PubMed] [Google Scholar]
  6. Blizzard R. M., Gibbs J. H. Candidiasis: studies pertaining to its association with endocrinopathies and pernicious anemia. Pediatrics. 1968 Aug;42(2):231–237. [PubMed] [Google Scholar]
  7. Cahill L. T., Ainbender E., Glade P. R. Chronic mucocutaneous candidiasis: T cell deficiency associated with B cell dysfunction in man. Cell Immunol. 1974 Nov;14(2):215–225. doi: 10.1016/0008-8749(74)90207-x. [DOI] [PubMed] [Google Scholar]
  8. Canales L., Middlemas R. O., 3rd, Louro J. M., South M. A. Immunological observations in chronic mucocutaneous candidiasis. Lancet. 1969 Sep 13;2(7620):567–571. doi: 10.1016/s0140-6736(69)90264-5. [DOI] [PubMed] [Google Scholar]
  9. Chan A. C., Sack K. Danazol therapy in autoimmune hemolytic anemia associated with systemic lupus erythematosus. J Rheumatol. 1991 Feb;18(2):280–282. [PubMed] [Google Scholar]
  10. Chilgren R. A., Meuwissen H. J., Quie P. G., Good R. A., Hong R. The cellular immune defect in chronic mucocutaneous candidiasis. Lancet. 1969 Jun 28;1(7609):1286–1288. doi: 10.1016/s0140-6736(69)92223-5. [DOI] [PubMed] [Google Scholar]
  11. Deeg H. J., Lum L. G., Sanders J., Levy G. J., Sullivan K. M., Beatty P., Thomas E. D., Storb R. Severe aplastic anemia associated with chronic mucocutaneous candidiasis. Immunologic and hematologic reconstitution after allogeneic bone marrow transplantation. Transplantation. 1986 May;41(5):583–586. doi: 10.1097/00007890-198605000-00006. [DOI] [PubMed] [Google Scholar]
  12. Drew J. H. Chronic mucocutaneous candidiasis with abnormal function of serum complement. Med J Aust. 1973 Jul 14;2(2):77–80. doi: 10.5694/j.1326-5377.1973.tb128656.x. [DOI] [PubMed] [Google Scholar]
  13. Durandy A., Fischer A., Le Deist F., Drouhet E., Griscelli C. Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis. J Clin Immunol. 1987 Sep;7(5):400–409. doi: 10.1007/BF00917018. [DOI] [PubMed] [Google Scholar]
  14. ESSELBORN V. M., LANDING B. H., WHITAKER J., WILLIAMS R. R. The syndrome of familial juvenile hypoadrenocorticism, hypoparathyroidism and superficial moniliasis. J Clin Endocrinol Metab. 1956 Oct;16(10):1374–1387. doi: 10.1210/jcem-16-10-1374. [DOI] [PubMed] [Google Scholar]
  15. Flynn P. M., Barrett F. F., Herrod H. G. Disseminated histoplasmosis in two patients with chronic mucocutaneous candidiasis. Pediatr Infect Dis J. 1987 Jul;6(7):691–693. doi: 10.1097/00006454-198707000-00018. [DOI] [PubMed] [Google Scholar]
  16. Gibson J. Autoimmune hemolytic anemia: current concepts. Aust N Z J Med. 1988 Jun;18(4):625–637. doi: 10.1111/j.1445-5994.1988.tb00138.x. [DOI] [PubMed] [Google Scholar]
  17. Gill F. F., Portnoy J. M. An unusual combination of immunologic abnormalities in a patient with chronic mucocutaneous candidiasis. Ann Allergy. 1989 Aug;63(2):98-100, 147-8. [PubMed] [Google Scholar]
  18. Gupta S. Autologous mixed lymphocyte reaction in man. XI. Deficiency of autologous mixed lymphocyte reaction and abnormalities of monoclonal antibody-defined T-cell subsets in chronic mucocutaneous candidiasis. Scand J Immunol. 1985 Jun;21(6):525–530. [PubMed] [Google Scholar]
  19. Herrod H. G. Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection: a report of the Pediatric Immunodeficiency Collaborative Study Group. J Pediatr. 1990 Mar;116(3):377–382. doi: 10.1016/s0022-3476(05)82824-0. [DOI] [PubMed] [Google Scholar]
  20. JANDL J. H., KAPLAN M. E. The destruction of red cells by antibodies in man. III. Quantitative factors influencing the patterns of hemolysis in vivo. J Clin Invest. 1960 Jul;39:1145–1156. doi: 10.1172/JCI104129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kauffman C. A., Shea M. J., Frame P. T. Invasive fungal infections in patients with chronic mucocutaneous candidiasis. Arch Intern Med. 1981 Jul;141(8):1076–1079. [PubMed] [Google Scholar]
  22. Kirkpatrick C. H. Chronic mucocutaneous candidiasis. Antibiotic and immunologic therapy. Ann N Y Acad Sci. 1988;544:471–480. doi: 10.1111/j.1749-6632.1988.tb40444.x. [DOI] [PubMed] [Google Scholar]
  23. Kirkpatrick C. H. Chronic mucocutaneous candidiasis. Eur J Clin Microbiol Infect Dis. 1989 May;8(5):448–456. doi: 10.1007/BF01964059. [DOI] [PubMed] [Google Scholar]
  24. Kirkpatrick C. H., Rich R. R., Bennett J. E. Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med. 1971 Jun;74(6):955–978. doi: 10.7326/0003-4819-74-6-955. [DOI] [PubMed] [Google Scholar]
  25. Mobacken H., Lindholm L., Moberg S. Immunological studies in chronic mucocutaneous candidiasis before and after ketoconazole treatment. Acta Derm Venereol. 1987;67(3):257–260. [PubMed] [Google Scholar]
  26. Mylvaganam R., Ahn Y. S., Harrington W. J., Kim C. I. Immune modulation by danazol in autoimmune thrombocytopenia. Clin Immunol Immunopathol. 1987 Mar;42(3):281–287. doi: 10.1016/0090-1229(87)90016-x. [DOI] [PubMed] [Google Scholar]
  27. Noh L. M., Hussein S. H., Sukumaran K. D., Rose I., Abdullah N. Chronic mucocutaneous candidiasis with deficient CD2 (E receptor) but normal CD3 mononuclear cells. J Clin Lab Immunol. 1991 Jun;35(2):89–93. [PubMed] [Google Scholar]
  28. Ruiz-Argüelles A., Jett J. R., Ritts R. E., Jr Impaired generation of helper T cells in a patient with chronic mucocutaneous candidiasis and malignant thymoma. J Clin Lab Immunol. 1983 Mar;10(3):165–169. [PubMed] [Google Scholar]
  29. Sander E., Prolla G., Marques A. R., Zelmanowitz T., Zampese M., Schwartsmann G. Reversal by interleukin-2 of alopecia universalis, mucocutaneous candidiasis, and sexual impotence in a patient with malignant thymoma. J Natl Cancer Inst. 1993 Apr 21;85(8):673–673. doi: 10.1093/jnci/85.8.673. [DOI] [PubMed] [Google Scholar]
  30. Schreiber A. D., Chien P., Tomaski A., Cines D. B. Effect of danazol in immune thrombocytopenic purpura. N Engl J Med. 1987 Feb 26;316(9):503–508. doi: 10.1056/NEJM198702263160903. [DOI] [PubMed] [Google Scholar]
  31. Schreiber A. D., Parsons J., McDermott P., Cooper R. A. Effect of corticosteroids on the human monocyte IgG and complement receptors. J Clin Invest. 1975 Nov;56(5):1189–1197. doi: 10.1172/JCI108196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Stobo J. D., Paul S., Van Scoy R. E., Hermans P. E. Suppressor thymus-derived lymphocytes in fungal infection. J Clin Invest. 1976 Feb;57(2):319–328. doi: 10.1172/JCI108283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Theofilopoulos A. N., Dixon F. J. Murine models of systemic lupus erythematosus. Adv Immunol. 1985;37:269–390. doi: 10.1016/s0065-2776(08)60342-9. [DOI] [PubMed] [Google Scholar]
  34. Van Scoy R. E., Hill H. R., Ritts R. E., Quie P. G. Familial neutrophil chemotaxis defect, recurrent bacterial infections, mucocutaneous candidiasis, and hyperimmunoglobulinemia E. Ann Intern Med. 1975 Jun;82(6):766–771. doi: 10.7326/0003-4819-82-6-766. [DOI] [PubMed] [Google Scholar]
  35. Waldmann T. A., Blaese R. M., Broder S., Krakauer R. S. Disorders of suppressor immunoregulatory cells in the pathogenesis of immunodeficiency and autoimmunity. Ann Intern Med. 1978 Feb;88(2):226–238. doi: 10.7326/0003-4819-88-2-226. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES